001065.KS
JW Pharmaceutical Corporation [001065.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
001065.KS Stock Summary
Top 10 Correlated ETFs
001065.KS
Top 10 Correlated Stocks
001065.KS
In the News
001065.KS Financial details
Company Rating
-
Market Cap
701.8B
Income
37.01B
Revenue
748.53B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.2K
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
0
Forward P/E
-
PEG
-
P/S
1.11
P/B
-
P/C
-
P/FCF
28.19
Quick Ratio
-
Current Ratio
1.16
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.43K
EPS next Y
-
EPS next Q
-
EPS this Y
18.69%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
7.92%
Revenue Q/Q
11.3%
EPS Q/Q
-234.82%
-
-
-
-
SMA20
-0.16%
SMA50
-6.23%
SMA100
-2.67%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
10%
ROC
0.28%
Gross Margin
45%
Oper. Margin
13%
Profit Margin
3%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0-35196.08
52W High
-
52W Low
-
RSI
66.31
Rel Volume
2.13
Avg Volume
232
Volume
494
Perf Week
2.7%
Perf Month
0.88%
Perf Quarter
-8.65%
Perf Half Y
-6.86%
-
-
-
-
Beta
0.607
-
-
Volatility
240.11%, 393.99%
Prev Close
1.97%
Price
28500
Change
3.45%
Company Profile
- Volume Average 232
- Market Capitalization 701.8B
- Employee 1.2K
- CEO Mr. Young-Sub Shin
- Headquarters Seoul,KR
- IPO Date 2005-09-29
-
Website
https://www.jw-pharma.co.kr 
JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.
